Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Diagnostic Yield and Variant Spectrum in 375 Patients with Segmental Overgrowth and Vascular Malformations: Implications for Panel Design and Molecular Testing Strategies

4 affiliations
  1. 1Research Centre for Medical Genetics, Moscow 115522, Russia
  2. 2National Medical Research Center of Oncology Named After N.N. Blokhin of the Ministry of Health of the Russian Federation, Moscow 115522, Russia
  3. 3Children’s State Clinical Hospital of St. Vladimir of Moscow City Health Department, Moscow 107014, Russia
  4. 4Children’s City Clinical Hospital Named After N.F. Filatov of Moscow City Health Department, Moscow 123242, Russia

Abstract

Segmental overgrowth and vascular malformations comprise a group of diseases caused by postzygotic variants in genes that regulate cell growth, proliferation, and angiogenesis. The best-characterized group is the PIK3CA-related overgrowth spectrum (PROS), which includes syndromes sharing variants in the PIK3CA gene. Beyond PIK3CA, the genes involved fall into two mechanistically distinct groups, with gain-of-function (GNAQ, GNA11, TEK, AKT1, AKT3, MTOR, PIK3R1) and loss-of-function (RASA1, GLMN, PTEN) causative variants. What remains poorly established is how effectively a molecular diagnosis is actually achieved in routine practice, and how this depends on the referral clinical diagnosis. By targeted panel deep sequencing in patients with segmental overgrowth and/or a vascular malformation, we have identified at least one pathogenic / likely pathogenic (P/LP) genetic variant in 266 of the 375 successfully tested patients, giving an overall diagnostic yield of 70.9%. The yield was 63.5% in patients with isolated overgrowth (94 of 148), 75.0% in patients with an isolated vascular malformation (111 of 148) and 77.2% in patients with a combined or syndromic phenotype (61 of 79). The 277 P/LP variants identified were distributed across 17 genes; PIK3CA accounted for 141 variants (50.9%), GNAQ for 44 (15.9%), TEK for 31 (11.2%), RASA1 for 15 (5.4%) and GNA11 for 11 (4.0%); these five genes together accounted for 87.4% of the variants. The spectrum was highly concentrated: the ten most frequent variants accounted for 57.0% of the P/LP variants, with GNAQ variant p.Arg183Gln (15.2%) and PIK3CA hotspot variants p.Glu542Lys (8.7%), p.Glu545Lys (6.9%), and p.His1047Arg (7.6%). In several genes, variants were restricted to specific regions: in GNAQ and GNA11 to two codons, 183 and 209 (98.2% of all findings), and in TEK to the 3′-terminus. Considered together with the referral diagnosis, the distribution of variants, their allele fractions and their mechanisms of pathogenicity suggest molecular testing strategies.

Related

  1. The Role of Neutrophil Extracellular Traps (NETosis) in Systemic Lupus Erythematosus: Molecular Mechanisms, Pathogenic Roles, Diagnostic Biomarkers, and Emerging Therapeutic Strategies
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. Drug-Induced Vitamin B12 Deficiency: Current Evidence, Diagnostic Challenges, and Therapeutic Strategies
    Ramón Costa Segovia, Lara Molines Guillem
    MetabolitesPeer-reviewedCC BY 4.0Proteomics & metabolomicsCrossref
  3. Research progress of extracellular vesicles in PMOS: molecular mechanisms, diagnostic value, and therapeutic strategies
    Lijing Qi, Yue Jiang, Yanhua Han +3
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMCPMC
  4. Role of METTL6 in gastric cancer: diagnostic, prognostic, and functional implications
    Dongdong Lu, Jie Lou, Leijie Huang +1
    PeerJPeer-reviewedCC BY 4.0Full textGeneral biochemistryBioinformatics & computational biologyCrossrefPMC
  5. Case Report A Rare Cause of Cardiofaciocutaneous Syndrome-KRAS p.Pro34arg: Clinical Delineation, Diagnostic Challenges, and Implications for RASopathy Classification.
    Francisco J Mérida De Ia Torre, Mónica Coll Vidal, Ivette Rubio Martínez +2
    Reports (MDPI)Peer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{bychkova2026diagnostic,
  title = {{Diagnostic Yield and Variant Spectrum in 375 Patients with Segmental Overgrowth and Vascular Malformations: Implications for Panel Design and Molecular Testing Strategies}},
  author = {Ekaterina V. Bychkova and Natalia A. Semenova and Garik B. Sagoyan and Seyfulla V. Alimov and Alexander E. Zhigulin and Grigory A. Somsikov and Ruslan A. Khagurov and Daria M. Guseva and Ilya V. Volodin and Sergey I. Kutsev and Vladimir V. Strelnikov},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210127},
  url = {https://www.mdpi.com/1422-0067/27/22/10127},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Diagnostic Yield and Variant Spectrum in 375 Patients with Segmental Overgrowth and Vascular Malformations: Implications for Panel Design and Molecular Testing Strategies
AU  - Ekaterina V. Bychkova
AU  - Natalia A. Semenova
AU  - Garik B. Sagoyan
AU  - Seyfulla V. Alimov
AU  - Alexander E. Zhigulin
AU  - Grigory A. Somsikov
AU  - Ruslan A. Khagurov
AU  - Daria M. Guseva
AU  - Ilya V. Volodin
AU  - Sergey I. Kutsev
AU  - Vladimir V. Strelnikov
PY  - 2026
DA  - 2026/11/12
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210127
UR  - https://www.mdpi.com/1422-0067/27/22/10127
AB  - Segmental overgrowth and vascular malformations comprise a group of diseases caused by postzygotic variants in genes that regulate cell growth, proliferation, and angiogenesis. The best-characterized group is the PIK3CA-related overgrowth spectrum (PROS), which includes syndromes sharing variants in the PIK3CA gene. Beyond PIK3CA, the genes involved fall into two mechanistically distinct groups, with gain-of-function (GNAQ, GNA11, TEK, AKT1, AKT3, MTOR, PIK3R1) and loss-of-function (RASA1, GLMN, PTEN) causative variants. What remains poorly established is how effectively a molecular diagnosis is actually achieved in routine practice, and how this depends on the referral clinical diagnosis. By targeted panel deep sequencing in patients with segmental overgrowth and/or a vascular malformation, we have identified at least one pathogenic / likely pathogenic (P/LP) genetic variant in 266 of the 375 successfully tested patients, giving an overall diagnostic yield of 70.9%. The yield was 63.5% in patients with isolated overgrowth (94 of 148), 75.0% in patients with an isolated vascular malformation (111 of 148) and 77.2% in patients with a combined or syndromic phenotype (61 of 79). The 277 P/LP variants identified were distributed across 17 genes; PIK3CA accounted for 141 variants (50.9%), GNAQ for 44 (15.9%), TEK for 31 (11.2%), RASA1 for 15 (5.4%) and GNA11 for 11 (4.0%); these five genes together accounted for 87.4% of the variants. The spectrum was highly concentrated: the ten most frequent variants accounted for 57.0% of the P/LP variants, with GNAQ variant p.Arg183Gln (15.2%) and PIK3CA hotspot variants p.Glu542Lys (8.7%), p.Glu545Lys (6.9%), and p.His1047Arg (7.6%). In several genes, variants were restricted to specific regions: in GNAQ and GNA11 to two codons, 183 and 209 (98.2% of all findings), and in TEK to the 3′-terminus. Considered together with the referral diagnosis, the distribution of variants, their allele fractions and their mechanisms of pathogenicity suggest molecular testing strategies.
SN  - 1422-0067
ER  -